The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, L. R.
Right arrow Articles by Pearlman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, L. R.
Right arrow Articles by Pearlman, E.
The Journal of Immunology, 2001, 167: 919-925.
Copyright © 2001 by The American Association of Immunologists

A Dominant Role for Fc{gamma} Receptors in Antibody-Dependent Corneal Inflammation1

Laurie R. Hall, Eugenia Diaconu and Eric Pearlman2

Departments of Medicine and Ophthalmology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although production of specific Ab is a critical element of host defense, the presence of Ab in tissues leads to formation of immune complexes, which can trigger a type III Arthus reaction. Our studies on a mouse model of river blindness showed that Ab production is essential for recruitment of neutrophils and eosinophils to the cornea and for development of corneal opacification. In the current study, we determined the relative contribution of complement and Fc{gamma}R interactions in triggering immune complex-mediated corneal disease. Fc{gamma}R-/- mice, C3-/- mice, and immunocompetent control (B6/129Sj) mice were immunized s.c. and injected intrastromally with Onchocerca volvulus Ags. Slit lamp examination showed that control mice, C3-/- mice, and control mice injected with cobra venom factor developed pronounced corneal opacification, whereas corneas of Fc{gamma}R-/- mice remained completely clear. Furthermore, recruitment of neutrophils and eosinophils to the corneal stroma was significantly impaired in Fc{gamma}R-/- mice, but not in C3-/- mice or cobra venom factor-treated mice. We therefore conclude that Fc{gamma}R-mediated cell activation, rather than complement activation, is the dominant pathway of immune complex disease in the cornea. These findings demonstrate a novel role for Fc{gamma}R interactions in mediating ocular inflammation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Deposition of soluble immune complexes in host tissue can trigger a type III or Arthus-type response, which mediates autoimmune diseases such as rheumatoid arthritis, glomerulonephritis, and systemic lupus erythematosus (1, 2, 3). However, the role of these responses in ocular inflammation, especially the pathogenesis of corneal diseases, has yet to be determined. Ab and complement are present in the human cornea at concentrations closer to that of serum than of tears, making it likely that the source of Ab and complement in the normally avascular cornea is peripheral blood vessels (4, 5).

Taken together, these observations imply that: 1) individuals with chronic infections are likely to have pathogen-specific Ab in the corneal stroma; and 2) infiltration of pathogens into the cornea and release of Ags would trigger immune complex formation and an Arthus-type response at this site. As the transparent nature of the cornea is tightly regulated by the parallel arrangement of collagen fibrils and by a strict level of hydration, development of an inflammatory response in this tissue will disrupt the normal physiology of the cornea, resulting in loss of corneal clarity, visual impairment, and possibly blindness.

Two pathways are involved in immune complex-mediated inflammatory responses. First, immune complexes can activate the complement cascade and generate peptide fragments C3a and C5a, which are highly chemotactic for neutrophils and eosinophils (6, 7). Second, immune complexes can bind to FcR on the cell surface and trigger cellular activation (2, 3). Ravetch and coworkers (8, 9) demonstrated that Fc{gamma}R interactions are essential for development of the reverse passive Arthus reaction in the skin, whereas the absence of complement components C3 or C4 had no effect. However, the relative contribution of FcR interactions and complement in development of immune complex disease depends on the genetic background of the host, and on the tissue that is involved (3, 10, 11, 12). For example, C5a receptor expression is important in immune complex-mediated alveolitis, but has less of a contribution in peritonitis and skin inflammation (12).

Our studies have focused on river blindness, which is the second leading cause of infectious blindness worldwide (13, 14, 15, 16).The parasitic nematode that causes this disease, Onchocerca volvulus, survives in the host for over 10 years in the presence of an ongoing T cell response and high titers of parasite-specific IgG1, IgG4, and IgE (16). The larval form of the parasite invades the cornea and posterior ocular tissue, causing severe visual impairment and eventual blindness. Epidemiological studies indicate that ocular inflammation and subsequent tissue damage develop only after parasite death and release of somatic Ags into the immediate environment (16, 17). Although immune complexes have been detected in the serum of O. volvulus-infected individuals, their role in the pathogenesis of this disease is not known (18, 19, 20). In the current study, we explore the possibility that the presence of O. volvulus Ags and parasite-specific Ab in the cornea triggers an Arthus-type reaction that drives the inflammatory response in ocular onchocerciasis.

We have developed a murine model of river blindness in which mice are immunized s.c. and then injected into the corneal stroma with O. volvulus Ags (15, 21). Immunized mice produce high titers of anti-parasite IgG, and develop pronounced corneal opacification and neovascularization (15, 22). In this model, neutrophil recruitment to the cornea peaks at 24 h after intracorneal injection, whereas eosinophil recruitment peaks after 72 h, completely replacing neutrophils as the predominant inflammatory cell type in the cornea (15, 22). Although neutrophils and eosinophils mediate corneal pathology that is similar in appearance, these cell types differ both in the molecular basis of recruitment to the cornea and in the cytotoxic mediators produced. For example, neutrophil infiltration is dependent on expression of platelet endothelial cell adhesion molecule-1 and expression of CXCR2, whereas eosinophil recruitment to the cornea is dependent on expression of P-selectin and ICAM-1, and is regulated by CD4+ cells (23, 24, 25, 26) and by eotaxin (53). These studies also demonstrated that complete inhibition of corneal pathology depends on blocking infiltration of both cell types to the cornea. Furthermore, whereas the primary cytotoxic activity of neutrophils is by generating reactive oxygen species, eosinophils also secrete cationic granule proteins such as eosinophil major basic protein, which are directly cytotoxic for resident corneal cells (27).

Results from several sets of experiments led us to conclude that formation of immune complexes is essential for development of O. volvulus keratitis, as corneal pathology is detected only when parasite Ags are injected in the presence of O. volvulus-specific Ab. For example, keratitis is not induced when parasite Ags are injected into unimmunized, immunocompetent mice (21), immunized Ab-deficient (µMT) mice (28), or immunized µMT mice together with normal mouse sera (28). Keratitis is induced in µMT mice only when parasite Ags are injected into the corneal stroma together with sera from immunized mice (28). Results from the current study provide further evidence for an essential role for immune complexes in this disease, as Fc{gamma}R-deficient mice fail to develop keratitis despite the presence of Ag in the cornea and high titer parasite-specific serum Ab. Furthermore, we found that O. volvulus-induced immune complex disease in the cornea is independent of the pivotal complement component C3.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Parasite Ags

O. volvulus worms were obtained from nodules that had been surgically removed from patients in Cameroon, and were kindly provided by J. Bradley (University of Nottingham, Nottingham, U.K.). Soluble O. volvulus Ags were prepared as described previously (21). Briefly, worms were isolated from s.c. nodules after digestion with collagenase (Sigma, St. Louis, MO). Parasites were homogenized in HBSS, sonicated, and centrifuged to remove insoluble material. The soluble O. volvulus Ag preparation was adjusted to 1 mg/ml, filter sterilized, and stored at -70°C.

Animals

Mice with a targeted deletion in the common FcR{gamma} chain (B6, 129-Fc{epsilon}r1gtm1Rav) were derived by Ravetch and coworkers (29), and were obtained from The Jackson Laboratory (Bar Harbor, ME). Control F2 generation mice were on same genetic background (B6/129SJ) and were also obtained from The Jackson Laboratory. C3-deficient mice on the same genetic background were derived by Carroll et al. (30), and were a kind gift from his laboratory. In some experiments, FcR{gamma} mice backcrossed to C57BL/6 background were obtained from Taconic Laboratories (Germantown, NY).

Immunization and intrastromal injection

Mice received three weekly s.c. immunizations with 10 µg O. volvulus Ags in a 1:1 ratio with adjuvant containing squalene (Aldrich Chemical, Milwaukee, WI), Tween 80 (Fisher, Fair Lawn, NJ), and pluronic acid (BASF, Parsippany, NJ). For intrastromal injections, the cornea was scarified with a 30-gauge needle, and 5 µg O. volvulus Ags were injected into the corneal stroma using a 33-gauge needle attached to a Hamilton syringe (Hamilton, Reno, NV). Corneal opacification was monitored daily by slit lamp examination and evaluated as previously described (21).

Depletion of C3 by treatment with cobra venom factor

Cobra venom factor (CVF)3 was obtained from Sigma (St. Louis, MO) and prepared at 20 µg/ml HBSS. A total of 0.5 ml was injected i.p. 1 day before intrastromal injection, the day of intrastromal injection, and each day before sacrifice. Control mice were injected with HBSS.

Immunohistochemistry

Eyes were removed, fixed for 18 h in 10% formaldehyde (Sigma), processed, and embedded in paraffin by standard methods. To detect neutrophils, 5-µm sections were immunostained with mAb NIMP-R14, followed by biotinylated rabbit anti-rat Ig (BioGenex, San Ramon, CA). Eosinophils were detected using rabbit antisera to major basic protein diluted 1/5000 for 2 h, as described (22, 28). After incubation with a secondary Ab, sections were incubated with alkaline phosphatase-conjugated streptavidin (BioGenex). Positive reactivity was visualized using Vector Red Substrate (Vector Laboratories, Burlingame, CA) containing Levamisole (Sigma), and counterstained with modified Harris’ hematoxylin (Richard-Allen, Kalamazoo, MI). Cells were visualized by bright field and fluorescent microscopy.

Measurement of serum IgG and C3 levels by ELISA

Sera were collected at the time of sacrifice and assayed for Ab by ELISA. Immulon-4 ELISA plates (Dynatech, Chantilly, VA) were coated with 50 µl of 1 µg/ml parasite Ags and incubated overnight at 4°C. After blocking with 1% FBS, dilutions of mouse sera were incubated 2 h at room temperature, washed, and incubated with biotinylated goat anti-mouse isotype-specific Abs (Southern Biotechnology, Birmingham, AL). Reactivity was determined after incubation with peroxidase-labeled anti-goat IgG (Santa Cruz Biotechnology, Santa Cruz, CA), and tetramethyl benzidine (Zymed, San Francisco, CA) was used as a substrate. Reaction was stopped after 10 min with 1 N HCl. Absorbance was measured at 450 nm on a kinetic microplate reader (Molecular Devices, Sunnyvale, CA).

Serum C3 levels were detected by ELISA using unconjugated anti-C3 to coat the wells, and HRP-conjugated anti-C3 as detecting Ab (Cappell, Aurora, OH). Serum C3 levels in mice treated with CVF were reduced >90%.

Statistics

p Values were determined by unpaired t test using Prism software (GraphPad, San Diego, CA). A value of <0.05 was considered to be statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Fc{gamma}R-/- expression is essential for development of O. volvulus-induced corneal disease

To determine the role of Fc{gamma}R expression on O. volvulus keratitis, Fc{gamma}R-/- and control, 129Sj/C57BL/6 mice were immunized s.c. and injected into the central cornea with O. volvulus Ags, and the severity of corneal opacification was determined by slit lamp examination. As shown in Fig. 1Go, control mice developed pronounced corneal opacification within 24 h after intrastromal injection, and corneas remained opaque throughout the course of the experiment. In marked contrast to control mice, corneas of Fc{gamma}R-/- mice failed to develop opacities and remained transparent throughout the study (Fig. 1Go, lower right panel).



View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 1. Requirement for Fc{gamma}R-/- expression in development of O. volvulus keratitis. Fc{gamma}R-/- mice and control, 129SJ/C57BL/6 mice were immunized and injected intrastromally with O. volvulus Ags. Corneal opacification was monitored daily by slit lamp examination and evaluated based on the extent and intensity of opacification, measured in 0.5-U increments. Data points represent the mean ± SEM of 10 eyes/group, with representative eyes shown above. The experiment was repeated twice with similar results. Representative eyes are shown from day 3 after intrastromal injection. Upper panel, Control mouse; lower panel, Fc{gamma}R-/- mice (original magnification is x20).

 
Neutrophil recruitment to the cornea is impaired in Fc{gamma}R-/- mice

Previous studies demonstrated that corneal opacification is associated with a biphasic recruitment of neutrophils and eosinophils to the corneal stroma, with neutrophils at maximal numbers in the first 24 h after intrastromal injection, and eosinophils the predominant inflammatory cell type after 72 h (15, 22, 28). To determine the role of Fc{gamma}R in extravasation of neutrophils from the limbus to the peripheral cornea and migration to the central cornea, control and Fc{gamma}R-/- mice were immunized and injected intrastromally with worm Ags, as described above. Neutrophils in the peripheral, paracentral, and central regions of the cornea were counted after immunostaining with Ab to neutrophil surface marker that does not react with eosinophils.

As shown previously for C57BL/6 mice (22, 28), neutrophils infiltrate into each region of the corneal stroma of control, immunocompetent mice within 24 h of intrastromal injection. The highest numbers were in the peripheral region of the corneal stroma and the fewest in the center, reflecting migration of these cells from limbal vessels to the site of trauma in the central cornea. However, neutrophil recruitment to the corneas of Fc{gamma}R-/- mice was significantly impaired in the peripheral cornea and in the paracentral and central regions of the cornea (Figs. 2Go and 3Go). This deficiency was not a result of delayed recruitment, as neutrophils were not detected in corneas of either strain of mice after 72 h (data not shown).



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 2. Impaired neutrophil recruitment to the cornea in Fc{gamma}R-/- mice. Fc{gamma}R-/- mice and control, 129SJ/C57BL/6 mice were immunized and challenged intrastromally with O. volvulus Ags. Animals were sacrificed 24 h later, and 5-µm corneal sections were immunostained with anti-neutrophil Ab. Cells were visualized after incubation with Vector Red, and positively stained cells in the peripheral, paracentral, and central regions of the cornea were counted in a masked fashion. Data points represent individual corneas. This experiment was repeated twice with similar results.

 


View larger version (84K):
[in this window]
[in a new window]
 
FIGURE 3. Neutrophils in peripheral corneal stroma of control and Fc{gamma}R-/- mice. Peripheral corneas of control (upper panels) and Fc{gamma}R-/- mice (lower panels) immunostained with anti-neutrophil Ab 24 h after intrastromal injection of parasite Ags. Sections were developed using Vector Red, and viewed by bright field (left panels) or fluorescence (right panels) microscopy. Original magnification is x200.

 
Eosinophil recruitment to the cornea is impaired in Fc{gamma}R-/- mice

To determine the effect of Fc{gamma}R deficiency on eosinophil infiltration of the cornea, Fc{gamma}R-/- and control, 129Sj/C57BL/6 mice were immunized s.c. and injected intrastromally, as described above. Mice were sacrificed 72 h later, and eosinophils were identified by immunostaining with Ab to eosinophil major basic protein. As shown for neutrophils, eosinophils were also recruited to peripheral, paracentral, and central regions of the corneas of immunocompetent, control mice (Figs. 4Go and 5Go). In contrast, eosinophil recruitment to the cornea was significantly impaired in Fc{gamma}R-/- mice compared with control, 129Sj/C57BL/6 mice. As shown previously for µMT mice (28), eosinophils’ recruitment from peripheral vessels to the peripheral cornea of Fc{gamma}R-/- mice was only partially impaired, whereas infiltration from the peripheral to the central cornea was completely inhibited in the absence of Fc{gamma}R expression.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 4. Impaired eosinophil recruitment to the cornea in Fc{gamma}R-/- mice. Fc{gamma}R-/- mice and control, 129SJ/C57BL/6 mice were immunized and challenged intrastromally with O. volvulus Ags. Mice were sacrificed 3 days later, and 5-µm corneal sections were immunostained with antisera to murine eosinophil major basic protein, and eosinophil numbers were determined as described in the legend to Fig. 2Go. Data points represent individual eyes. This experiment was repeated twice with similar results.

 


View larger version (81K):
[in this window]
[in a new window]
 
FIGURE 5. Eosinophils in peripheral corneal stroma of control and Fc{gamma}R-/- mice. Peripheral corneas of control (upper panels) and Fc{gamma}R-/- mice (lower panels) immunostained with anti-major basic protein Ab 72 h after intrastromal injection of parasite Ags. Sections were visualized as described in the legend to Fig. 2Go. Original magnification is x200.

 
Ab isotype responses to parasite Ags in Fc{gamma}R-/- mice

To determine whether the severity of corneal disease and recruitment of neutrophils and eosinophils are related to differences in Ag-specific isotype production, we measured IgG1 and IgG2a responses in Fc{gamma}R-/- mice. As shown in Fig. 6Go, parasite-specific IgG1 production was elevated compared with IgG2a in Fc{gamma}R-/- mice, consistent with a predominant Th2-associated response shown previously for immunocompetent mice (21). However, there was no significant difference between parasite-specific Ab titers in Fc{gamma}R-/- mice compared with control mice. These data indicate that Fc{gamma}R expression is not essential for development of Th2 responses, and also suggest that impaired neutrophil and eosinophil recruitment to the cornea is not due to a deficiency in Ab production or a switch in isotype of parasite-specific Ab.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 6. O. volvulus-specific IgG1 and IgG2a responses in Fc{gamma}R-/- mice. Fc{gamma}R-/- and control, 129SJ/C57BL/6 mice were immunized s.c. with O. volvulus Ags. IgG1 and IgG2a response to O. volvulus Ags were measured by ELISA, as described in Materials and Methods. Reciprocal titers are presented as mean ± SD of five mice per group. The experiment was repeated twice with similar results.

 
C3 deficiency or depletion does not inhibit development of O. volvulus keratitis

Two approaches were taken to determine the effect of complement on development of O. volvulus keratitis. First, C3-/- mice were immunized and injected using the same experimental protocol as Fc{gamma}R-/- mice, and second, mice were depleted of C3 by i.p. injection of CVF. Systemic administration of CVF depletes complement not only from the serum, but also from the cornea (31). Serum complement levels after i.p. injection of CVF were reduced by >90% (OD450 0.84 +/- 0.06 for control, saline-injected mice; 0.07 +/- 0.01 in CVF-treated mice).

As shown in Fig. 7Go, the total number of neutrophils and eosinophils in the corneal stroma of C3-/- mice and CVF-treated mice was not significantly different from control animals, and there was no difference in distribution of these cells within the corneal stroma. Furthermore, there were no significant differences in corneal opacification scores between control mice and either C3-/- mice or C3-depleted mice at any time point (data not shown).



View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 7. Neutrophil and eosinophil migration to the cornea in complement-depleted and C3-/- mice. Control B6/129Sj mice and C3-/- mice were immunized s.c. and challenged intrastromally with O. volvulus Ags. One group of control mice was injected i.p. with CVF or with saline (HBSS). The number of neutrophils in the cornea was determined at 24 h, and the number of eosinophils at 72 h after intrastromal injection. There were no significant differences (p > 0.05) in the total number of neutrophils or eosinophils in the cornea between control and C3-/- mice (upper panels), or between HBSS- and CVF-treated mice (lower panels). The experiment was repeated twice with similar results.

 
Taken together, these findings demonstrate that complement-mediated pathways are not essential for neutrophil and eosinophil recruitment to the cornea, nor for development of corneal disease.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Results of the current study extend our previous observations on the role of Ab in O. volvulus keratitis (28), and demonstrate a dominant role for Fc{gamma}R-mediated responses that is independent of C3. Our findings differ from other models of infectious keratitis and of helminth-induced immunopathology. In Pseudomonas aeruginosa keratitis, for example, depletion of C3 with CVF abrogates development of stromal disease, indicating an essential role for complement (32, 33). Also, our findings that Fc{gamma}R interactions have a proinflammatory role in ocular onchocerciasis differ from the antiinflammatory role of Fc{gamma}R in granuloma formation in mice infected with the parasitic helminth Schistosoma mansoni, in which Fc{gamma}R-/- mice failed to down-regulate liver granulomas (34).

The dominant role for Fc{gamma}R-mediated interactions over complement in the current study is consistent with findings by Ravetch and coworkers (8, 35) using a murine model of reverse Arthus reaction. In those studies, Fc{gamma}R-/- mice had reduced neutrophil infiltration, edema, and hemorrhage compared with control animals, whereas Arthus responses developed normally in C3-/- and C4-/- mice, and in animals depleted of C3 using CVF (8, 9). However, studies in which C5a receptor interactions were blocked using either receptor antagonists or C5aR-deficient mice indicate an important contribution of C5a receptors in immune complex disease, although the relative contribution depends on the tissue involved (10, 12, 36). The apparent paradox that C5a contributes to the inflammatory response in the absence of C3 may be explained by local production of complement components in affected tissues (10). Various cell types, including mononuclear phagocytes, endothelial cells, and corneal fibroblasts, can produce C3 and C5, and neutrophils and macrophages can secrete the proteases that cleave them (10, 37).

The relative contribution of complement to immune complex disease also has a genetic component, with C57BL/6 mice less susceptible to complement-mediated immune complex disease than BALB/c mice, which have a codominant role together with FcR (11, 36). In the present study, we found that CVF treatment did not inhibit development of keratitis B6/129Sj mice; however, we also found similar results in CVF-treated BALB/c and C57BL/6 mice, indicating that there are no apparent strain differences in response to CVF (L. R. Hall, unpublished observations). Together with our findings that C3-/- mice develop O. volvulus keratitis with the same intensity as immunocompetent control animals, we conclude that C3 has no essential role in this model of immune complex disease. However, as resident stromal fibroblasts can synthesize complement components (37), future studies will examine whether C5a receptor interactions function independently from C3 in O. volvulus keratitis.

Resident cells in the cornea, including epithelial cells and stromal fibroblasts, can also be induced to express FcR in vitro (38, 39). However, it is likely that Fc{gamma}R-dependent keratitis is mediated primarily by infiltrating neutrophils and eosinophils, with resident cells involved only in initial recruitment of neutrophils by an Fc{gamma}R-independent pathway. Although this has yet to be verified, our recent studies demonstrate that CXCR2 mediates neutrophil recruitment to the corneal stroma, and that neutrophil chemokines macrophage-inflammatory protein (MIP)-2 and KC are produced in the corneal stroma rather than the epithelium (24). Taken together with in vitro studies showing that human keratocytes can secrete IL-8 (40), it is feasible that stromal keratocytes mediate early recruitment of neutrophils by producing MIP-2 and KC. Once these cells infiltrate the cornea, we speculate that binding of immune complexes to Fc{gamma}R on the neutrophil surface stimulates production of chemotactic and immunoregulatory cytokines such as IL-12 and MIP-1{alpha} (41, 42).

The high affinity Fc{gamma}RI and the low affinity Fc{gamma}RIII, which are nonfunctional in Fc{gamma}R-/- mice, are multimeric receptors with ligand binding and signaling subunits. The signaling subunit for Fc{gamma}RI and Fc{gamma}RIII is the immunoreceptor tyrosine-based activation motif (ITAM), which mediates cell activation signals such as production of proinflammatory cytokines (3, 43). In contrast, Fc{gamma}RII is a single subunit receptor that signals through the immunoreceptor tyrosine-based inhibitor motif, which can inhibit ITAM-mediated cell activation (44, 45). As neutrophils and eosinophils express more than one type of Fc{gamma}R on their surface, interactions with IgG-containing immune complexes may result in coaggregation of different Fc{gamma}R, and the balance of activating and inhibitory Fc{gamma}R signals most likely determines the function of these effector cells in the cornea. In the current study, the finding that ocular inflammation is dependent on Fc{gamma}RI and Fc{gamma}RIII expression indicates that inflammation is dependent on ITAM signaling. Future studies will examine the interplay of ITAM and immunoreceptor tyrosine-based inhibitor motif-mediated interactions in ocular disease.

The common {gamma}-chain of the FcR is an integral part not only of Fc{gamma}RI and Fc{gamma}RIII, but also the high affinity IgE receptor Fc{epsilon}RI (2). However, although IgE levels are elevated in infected individuals and immunized animals (16, 21), it is unlikely that Fc{epsilon}RI is involved in O. volvulus keratitis, as this receptor is not expressed by neutrophils or by murine eosinophils (2, 46). Mast cells, which mediate the reverse Arthus response (35), have not been detected in O. volvulus keratitis.

In addition to chemotactic and immunoregulatory cytokines produced by neutrophils, ITAM-mediated interactions may trigger release of cytotoxic mediators from neutrophils, including oxygen radicals and proteolytic enzymes (47). Similarly, Fc{gamma}R stimulation of eosinophils could stimulate production of chemotactic and immunoregulatory cytokines such as eotaxin, IL-4, and IFN-{gamma} (48, 49, 50), and release of granule proteins such as eosinophil major basic protein, which has a direct cytotoxic effect on corneal epithelial cells (27, 51, 52). The presence of these mediators in the tightly regulated environment of the corneal stroma could then disrupt the function of epithelial cells and corneal endothelial cells, which maintain the critical hydration level of the stroma, resulting in stromal edema, and opacification of normally transparent cornea. Similarly, a cytotoxic effect on stromal keratocytes would adversely affect the structural integrity and spacing of the collagen fibrils.

Our previous studies demonstrated that O. volvulus keratitis is dependent on development of a CD4+, Th2-associated response, consistent with a type IV response (21). However, it appears that the primary role for the Th2 response is to generate parasite-specific IgG1 and IgE by production of IL-4, and to induce differentiation and maturation of eosinophils by production of IL-5. Although CD4+ cells also regulate eosinophil recruitment to the cornea at the later stage of disease (23), results of the present study indicate that immune complex formation is essential for mediating the inflammatory response in the cornea. In the absence of specific Ab, neutrophil and eosinophil recruitment to the central cornea is significantly impaired, and corneas remain transparent (28). However, the current study shows that even in the presence of high titer anti-parasite IgG, Fc{gamma}R expression is essential for development of keratitis.

In conclusion, the findings presented in this work represent a novel role for Fc{gamma}R interactions in mediating ocular inflammation and loss of vision.


    Acknowledgments
 
We thank Dr. James Lee for antisera to mouse major basic protein, and Dr. Achim Hoerauf for anti-neutrophil Ab. We also thank Drs. Fred Heinzel, Nathan Blackwell, and Abram Stavitsky for critical reading of the manuscript.


    Footnotes
 
1 This work was supported by National Institutes of Health Grants EY06913 (to L.R.H.) and EY10320 (to E.P.), and by funding from National Institutes of Health Grant EY11373, the Ohio Lions Eye Research Foundation, and the Research to Prevent Blindness Foundation. Back

2 Address correspondence and reprint requests to Dr. Eric Pearlman, Division of Geographic Medicine, Case Western Reserve University School of Medicine, W137, 2109 Adelbert Road, Cleveland, OH 44106. E-mail address: exp2{at}po.cwru.edu Back

3 Abbreviations used in this paper: CVF, cobra venom factor; ITAM, immunoreceptor tyrosine-based activation motif; MIP, macrophage-inflammatory protein. Back

Received for publication March 6, 2001. Accepted for publication May 4, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Clynes, R., C. Dumitru, J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052.[Abstract/Free Full Text]
  2. Ravetch, J. V., J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457.[Medline]
  3. Ravetch, J. V., R. A. Clynes. 1998. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16:421.[Medline]
  4. Allansmith, M. R., B. H. McClellan. 1975. Immunoglobulins in the human cornea. Am. J. Ophthalmol. 80:123.[Medline]
  5. Mondino, B. J., K. J. Brady. 1981. Distribution of hemolytic complement in the normal cornea. Arch. Ophthalmol. 99:1430.[Abstract/Free Full Text]
  6. Daffern, P. J., P. H. Pfeifer, J. A. Ember, T. E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:2119.[Abstract/Free Full Text]
  7. Gerard, C., N. P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775.[Medline]
  8. Sylvestre, D. L., J. V. Ravetch. 1994. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265:1095.[Abstract/Free Full Text]
  9. Sylvestre, D., R. Clynes, M. Ma, H. Warren, M. C. Carroll, J. V. Ravetch. 1996. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J. Exp. Med. 184:2385.[Abstract/Free Full Text]
  10. Kohl, J., J. E. Gessner. 1999. On the role of complement and Fc{gamma}-receptors in the Arthus reaction. Mol. Immunol. 36:893.[Medline]
  11. Baumann, U., J. Kohl, T. Tschernig, K. Schwerter-Strumpf, J. S. Verbeek, R. E. Schmidt, J. E. Gessner. 2000. A codominant role of Fc{gamma}RI/III and C5aR in the reverse Arthus reaction. J. Immunol. 164:1065.[Abstract/Free Full Text]
  12. Hopken, U. E., B. Lu, N. P. Gerard, C. Gerard. 1997. Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 186:749.[Abstract/Free Full Text]
  13. Abiose, A.. 1998. Onchocercal eye disease and the impact of Mectizan treatment. Ann. Trop. Med. Parasitol. 92:S11.
  14. Dadzie, K.. 1998. Control of onchocerciasis: challenges for the future. Ann. Trop. Med. Parasitol. 92:S65.
  15. Hall, L. R., E. Pearlman. 1999. Pathogenesis of onchocercal keratitis (river blindness). Clin. Microbiol. Rev. 12:445.[Abstract/Free Full Text]
  16. Ottesen, E.. 1995. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171:659.[Medline]
  17. Mackenzie, C. D., J. F. Williams, B. M. Sisley, M. W. Steward, J. O’Day. 1985. Variations in host responses and the pathogenesis of human onchocerciasis. Rev. Infect. Dis. 7:802.[Medline]
  18. Greene, B. M., H. R. Taylor, E. J. Brown, R. L. Humphrey, T. J. Lawley. 1983. Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes. J. Infect. Dis. 147:890.[Medline]
  19. Paganelli, R., J. L. Ngu, R. J. Levinsky. 1980. Circulating immune complexes in onchocerciasis. Clin. Exp. Immunol. 39:570.[Medline]
  20. Sisley, B. M., C. D. Mackenzie, M. W. Steward, J. F. Williams, J. O’Day, A. J. Luty, M. Braga, H. el Sheikh. 1987. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis. Parasite Immunol. 9:447.[Medline]
  21. Pearlman, E., J. H. Lass, D. S. Bardenstein, M. Kopf, Jr F. E. Hazlett, E. Diaconu, J. W. Kazura. 1995. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J. Exp. Med. 182:931.[Abstract/Free Full Text]
  22. Pearlman, E., L. R. Hall, A. W. Higgins, D. S. Bardenstein, E. Diaconu, F. E. Hazlett, J. Albright, J. W. Kazura, J. H. Lass. 1998. The role of eosinophils and neutrophils in helminth-induced keratitis. [Published erratum appears in 1998 Invest. Ophthalmol. Visual Sci. 39:1641.]. Invest. Ophthalmol. Visual Sci. 39:1176.[Abstract/Free Full Text]
  23. Hall, L. R., J. T. Kaifi, E. Diaconu, E. Pearlman. 2000. CD4(+) depletion selectively inhibits eosinophil recruitment to the cornea and abrogates Onchocerca volvulus keratitis (river blindness). Infect. Immun. 68:5459.[Abstract/Free Full Text]
  24. Hall, L. R., E. Diaconu, R. Patel, E. Pearlman. 2001. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J. Immunol. 166:4035.[Abstract/Free Full Text]
  25. Kaifi, J. T., L. R. Hall, C. Diaz, J. Sypek, E. Diaconu, J. H. Lass, E. Pearlman. 2000. Impaired eosinophil recruitment to the cornea in P-selectin-deficient mice in Onchocerca volvulus keratitis (river blindness). Invest. Ophthalmol. Visual Sci. 41:3856.[Abstract/Free Full Text]
  26. Kaifi, J., E. Diaconu, E. Pearlman. 2001. Distinct roles for PECAM-1, ICAM-1 and VCAM-1 in extravasation of neutrophils and eosinophils to the cornea in Onchocerca volvulus keratitis (river blindness). J. Immunol. 166:6975.
  27. Trocme, S., C. Hallberg, K. Gill, G. Gleich, S. Tyring, M. Brysk. 1997. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest. Ophthalmol. Visual Sci. 38:593.[Abstract/Free Full Text]
  28. Hall, L. R., J. H. Lass, E. Diaconu, E. R. Strine, E. Pearlman. 1999. An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (µMT) mice fail to develop Th2-dependent, helminth-mediated keratitis. J. Immunol. 163:4970.[Abstract/Free Full Text]
  29. Takai, T., M. Li, D. Sylvestre, R. Clynes, J. V. Ravetch. 1994. FcR{gamma} chain deletion results in pleiotrophic effector cell defects. Cell 76:519.[Medline]
  30. Wessels, M. R., P. Butko, M. Ma, H. B. Warren, A. L. Lage, M. C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92:11490.[Abstract/Free Full Text]
  31. Pleyer, U., B. J. Mondino, H. L. Sumner. 1992. The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs. Invest. Ophthalmol. Visual Sci. 33:2212.[Abstract/Free Full Text]
  32. Hazlett, L. D., R. S. Berk. 1984. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis. Infect. Immun. 43:783.[Abstract/Free Full Text]
  33. Cleveland, R. P., L. D. Hazlett, M. A. Leon, R. S. Berk. 1983. Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. Invest. Ophthalmol. Visual Sci. 24:237.[Abstract/Free Full Text]
  34. Jankovic, D., A. W. Cheever, M. C. Kullberg, T. A. Wynn, G. Yap, P. Caspar, F. A. Lewis, R. Clynes, J. V. Ravetch, A. Sher. 1998. CD4+ T cell-mediated granulomatous pathology in schistosomiasis is down-regulated by a B cell-dependent mechanism requiring Fc receptor signaling. J. Exp. Med. 187:619.[Abstract/Free Full Text]
  35. Sylvestre, D. L., J. V. Ravetch. 1996. A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 5:387.[Medline]
  36. Heller, T., J. E. Gessner, R. E. Schmidt, A. Klos, W. Bautsch, J. Kohl. 1999. Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J. Immunol. 162:5657.[Abstract/Free Full Text]
  37. Mondino, B. J., C. V. Sundar-Raj, K. J. Brady. 1982. Production of first component of complement by corneal fibroblasts in tissue culture. Arch. Ophthalmol. 100:478.[Abstract/Free Full Text]
  38. Hatano, H., J. O. Oh, K. H. Ou, P. Minasi. 1988. Induction of Fc and C3b receptors on rabbit corneal cells by herpes simplex virus. Invest. Ophthalmol. Visual Sci. 29:1352.[Abstract/Free Full Text]
  39. Wang, H. M., J. E. Jeng, H. J. Kaplan. 1989. Fc receptors in corneal epithelium. Curr. Eye Res. 8:123.[Medline]
  40. Cubitt, C., Q. Tang, C. Monteiro, R. Lausch, J. Oakes. 1993. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Visual Sci. 34:3199.[Abstract/Free Full Text]
  41. Bliss, S. K., B. A. Butcher, E. Y. Denkers. 2000. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J. Immunol. 165:4515.[Abstract/Free Full Text]
  42. Bliss, S. K., A. J. Marshall, Y. Zhang, E. Y. Denkers. 1999. Human polymorphonuclear leukocytes produce IL-12, TNF-{alpha}, and the chemokines macrophage-inflammatory protein-1{alpha} and -1{beta} in response to Toxoplasma gondii antigens. J. Immunol. 162:7369.[Abstract/Free Full Text]
  43. Clynes, R., J. S. Maizes, R. Guinamard, M. Ono, T. Takai, J. V. Ravetch. 1999. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:179.[Abstract/Free Full Text]
  44. Daeron, M., S. Latour, O. Malbec, E. Espinosa, P. Pina, S. Pasmans, W. H. Fridman. 1995. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc{gamma}RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635.[Medline]
  45. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M. C. Nussenzweig, J. V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc{gamma}RIIB modulates B-cell receptor signalling. Nature 368:70.[Medline]
  46. de Andres, B., E. Rakasz, M. Hagen, M. L. McCormik, A. L. Mueller, D. Elliot, A. Metwali, M. Sandor, B. E. Britigan, J. V. Weinstock, R. G. Lynch. 1997. Lack of Fc-{epsilon} receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 89:3826.[Abstract/Free Full Text]
  47. Smith, J. A.. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56:672.[Abstract]
  48. Sabin, E. A., M. A. Kopf, E. J. Pearce. 1996. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. Med. 184:1871.[Abstract/Free Full Text]
  49. Woerly, G., N. Roger, S. Loiseau, D. Dombrowicz, A. Capron, M. Capron. 1999. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon {gamma}): inhibition by immunoglobulin A complexes. J. Exp. Med. 190:487.[Abstract/Free Full Text]
  50. Woerly, G., N. Roger, S. Loiseau, M. Capron. 1999. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int. Arch. Allergy Immunol. 118:95.[Medline]
  51. Gleich, G. J., C. R. Adolphson, K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85.[Medline]
  52. Martin, L. B., H. Kita, K. M. Lieferman, G. J. Gleich. 1996. Eosinophils in allergy: role in disease, degranulation and cytokines. Int. Arch. Allergy Immunol. 109:207.[Medline]
  53. Rothenberg, M. E., J. Maclean, E. Pearlman, A. D. Luster, P. Leder. 1997. Targeted disruption of the chemokine eotaxin reduces peripheral blood and antigen induced tissue eosinophilia. J. Exp. Med. 185:785.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Infect. Immun.Home page
K. Gentil and E. Pearlman
Gamma Interferon and Interleukin-1 Receptor 1 Regulate Neutrophil Recruitment to the Corneal Stroma in a Murine Model of Onchocerca volvulus Keratitis
Infect. Immun., April 1, 2009; 77(4): 1606 - 1612.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
M. M. M. Ali, G. ElGhazali, S. M. Montgomery, S. E. Farouk, A. Nasr, S. I. A. Noori, M. M. Shamad, O. E. Fadlelseed, and K. Berzins
Fc{gamma}RIIa (CD32) Polymorphism and Onchocercal Skin Disease: Implications for the Development of Severe Reactive Onchodermatitis (ROD)
Am J Trop Med Hyg, December 1, 2007; 77(6): 1074 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. O. Beenhouwer, E. M. Yoo, C.-W. Lai, M. A. Rocha, and S. L. Morrison
Human Immunoglobulin G2 (IgG2) and IgG4, but Not IgG1 or IgG3, Protect Mice against Cryptococcus neoformans Infection
Infect. Immun., March 1, 2007; 75(3): 1424 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. Gillette-Ferguson, A. G. Hise, Y. Sun, E. Diaconu, H. F. McGarry, M. J. Taylor, and E. Pearlman
Wolbachia- and Onchocerca volvulus-Induced Keratitis (River Blindness) Is Dependent on Myeloid Differentiation Factor 88
Infect. Immun., April 1, 2006; 74(4): 2442 - 2445.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Casadevall and L.-a. Pirofski
New Concepts in Antibody-Mediated Immunity
Infect. Immun., November 1, 2004; 72(11): 6191 - 6196.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
J. A. Ligas, L. A. Kerepesi, A. M. Galioto, S. Lustigman, T. J. Nolan, G. A. Schad, and D. Abraham
Specificity and Mechanism of Immunoglobulin M (IgM)- and IgG-Dependent Protective Immunity to Larval Strongyloides stercoralis in Mice
Infect. Immun., December 1, 2003; 71(12): 6835 - 6843.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. v. S. Andre, N. M. Blackwell, L. R. Hall, A. Hoerauf, N. W. Brattig, L. Volkmann, M. J. Taylor, L. Ford, A. G. Hise, J. H. Lass, et al.
The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River Blindness
Science, March 8, 2002; 295(5561): 1892 - 1895.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, L. R.
Right arrow Articles by Pearlman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, L. R.
Right arrow Articles by Pearlman, E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS